ACTIVE

Crohn - en Colitis ulcerosa Vereniging vzw

Financial year 2025 · Closed on 31/12/2025

Net result83,6 k €+884,3 %over 1 year

Revenue220,1 k €+153,1 %over 1 year

Equity145,4 k €+135,3 %over 1 year

Identity

Source · BCE/KBO

Crohn - en Colitis ulcerosa Vereniging vzw is a Non-profit organization incorporated in 1981. Its main activity is: Activities of other membership organisations n.e.c.. Its registered office is in Leuven.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0422.701.650
Incorporation: 20/12/1981
Legal form: Non-profit organization
Registered office: Groeneweg 151
3001 Leuven · FlandreSee on map
Latest accounts: 31/12/2025

Activities (NACE)

94993Activities of other membership organisations n.e.c.· main 94993Activities of other membership organisations n.e.c.

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 6 filings

Trend over 6 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	220,1 k €	+153%	86,9 k €		–		63,4 k €		–
EBITDA	83,3 k €	+827%	9 k €	+124%	-38 k €	-17.7%	-32,3 k €	+52.9%	-68,5 k €
Operating result	83,3 k €	+871%	8,6 k €	+122%	-38,4 k €	-17.5%	-32,7 k €	+52.6%	-68,9 k €
Net result	83,6 k €	+884%	8,5 k €	+122%	-38,5 k €	-15.7%	-33,3 k €	+52.1%	-69,5 k €
Balance sheet
Equity	145,4 k €	+135%	61,8 k €	+15.9%	53,3 k €	-41.9%	91,8 k €	-26.6%	125,1 k €
Total assets	172,8 k €	+20.4%	143,5 k €	+98.4%	72,3 k €	-40.3%	121,2 k €	-23.6%	158,6 k €
Cash	158,6 k €	+18.9%	133,4 k €	+108%	64,2 k €	-35.3%	99,2 k €	-28.4%	138,5 k €
Debts	8,7 k €	-55.2%	19,3 k €	+138%	8,1 k €	-24.2%	10,7 k €	-33.1%	16 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Colette Baisier	Vice-chairman of the board of directorsuntil 23/03/2027Directorended
Frieda Wieme	Directoruntil 23/03/2027
Gemma Reynders-Broos	Directoruntil 23/03/2027
Ilse De Clercq	Directoruntil 23/03/2027
Kathleen Van Swalm	Directoruntil 23/03/2027
Kristien Amter	Directoruntil 23/03/2027
Lynn Debrun	Chairman of the board of directorsuntil 23/03/2027
Mariëlle De Ridder	Directoruntil 23/03/2027
Mark De Backer	Directoruntil 23/03/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Geert Theunis	Directoruntil 23/03/2027
Gemma Broos	Director

Other companies at this address

Groeneweg 151 3001 Leuven

Company	CBE no.
Fonds Similes● Active	0424.237.517
Similes Vlaanderen● Active	0413.066.283
SocA● Active	0702.852.003
Vrienden van Similes● Liquidation	0420.936.052

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/04/2026	03/04/2025	12/04/2024	07/04/2023	27/04/2022	18/03/2021
General meeting	03/03/2026	27/03/2025	03/04/2024	23/03/2023	21/04/2022	12/03/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 6 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	03/03/2026	02/04/2026	Dutch	PDF
Micro model	31/12/2024	27/03/2025	03/04/2025	Dutch	PDF
Micro model	31/12/2023	03/04/2024	12/04/2024	Dutch	PDF
Micro model	31/12/2022	23/03/2023	07/04/2023	Dutch	PDF
Micro model	31/12/2021	21/04/2022	27/04/2022	Dutch	PDF
Micro model	31/12/2020	12/03/2021	18/03/2021	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Colette Baisier	Vice-chairman of the board of directorsuntil 23/03/2027Directorended
Frieda Wieme	Directoruntil 23/03/2027
Gemma Reynders-Broos	Directoruntil 23/03/2027
Ilse De Clercq	Directoruntil 23/03/2027
Kathleen Van Swalm	Directoruntil 23/03/2027
Kristien Amter	Directoruntil 23/03/2027
Lynn Debrun	Chairman of the board of directorsuntil 23/03/2027
Mariëlle De Ridder	Directoruntil 23/03/2027
Mark De Backer	Directoruntil 23/03/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Geert Theunis	Directoruntil 23/03/2027
Gemma Broos	Director

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other10/06/2026
Wijziging samenstelling Bestuursorgaan
PDF
Mandates23/10/2024
Benaming,Ontslagen, Benoemingen,Wijziging statuten
PDF
Mandates03/05/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/05/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/05/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/04/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates02/05/2018
ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates08/05/2017
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings6 filings

Mandates

Colette Baisier

Mark De Backer

Ilse De Clercq

Frieda Wieme

Lynn Debrun

Kristien Amter

Gemma Reynders-Broos

Kathleen Van Swalm

Mariëlle De Ridder

Marleen Reynders

Geert Theunis

Johan Reynders

19811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Crohn- en Colitis Ulcerosavereniging

Groeneweg 151, 3001 Heverlee

Vice-chairman of the board of directors

Director

Chairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Groeneweg 151, 3001 HeverleeCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00070990

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Crohn - en Colitis ulcerosa Vereniging vzwCurrent		CBE
Crohn- en Colitis Ulcerosavereniging	accounts 2021 → 2025	Accounts 2025 · 2026-00070990

Events

2025
Annual accounts 202583,6 k €↑
2024
Annual accounts 20248,5 k €↑
2023
Annual accounts 2023-38,5 k €↓
2022
Annual accounts 2022-33,3 k €↑
2021
Annual accounts 2021-69,5 k €↓
2020
Annual accounts 202016,3 k €
20/12/1981
IncorporationNon-profit organization

Crohn - en Colitis ulcerosa Vereniging vzw

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events